Treatment of Polymyositis in Adults Aged 18 Years or Older
Polymyositis is an inflammatory muscle disease requiring a structured, evidence-based treatment approach. This protocol is designed specifically for adult patients aged 18 years or older.
Clinical Scenario
This protocol applies to adults aged 18 years or older presenting with Polymyositis. The approach accounts for the clinical profile and treatment history appropriate to this adult population.
Treatment Approach
The regimen for this scenario involves a targeted biologic agent considered for adult patients with this condition. Full regimen details, sequencing, and criteria are available in the complete protocol →
References
DOI: 10.1093/rheumatology/keac115
Abatacept is to be considered as a treatment option in refractory adult IIM.
View source ↗